Life
GSK Discontinues Leucovorin Once More
In the latest health news, GSK has announced another departure from leucovorin, alongside updates on a revised ACIP charter and issues related to sports betting and gambling addiction.
editorial-staff
1 min read
Updated 1 day ago
Summary
GSK has confirmed its decision to discontinue leucovorin, marking yet another chapter in the drug's history.
This announcement comes amidst broader discussions in health news, including a revised charter from the Advisory Committee on Immunization Practices (ACIP).
Additionally, topics such as sports betting and gambling addiction are gaining attention, reflecting ongoing concerns in public health.
Updates
- No subsequent updates recorded.